Skip to content
  1. Home
  2. Latest news
  3. Health & wellness
  4. Made in the shade: A new study looks at why a beach umbrella and high SPF sunscreen could be a good combo
JAMA Sunscreen Image

Made in the shade: A new study looks at why a beach umbrella and high SPF sunscreen could be a good combo

Have these dark and dreary winter days inspired you to plan a trip to the Caribbean? Before you make a beeline for that beach umbrella, don’t forget to apply some high SPF sunscreen.

According to a Johnson & Johnson study recently published in JAMA Dermatology, researchers found that sitting in the shade alone doesn’t adequately protect your skin from the sun’s harmful UV rays. Study participants who spent 3.5 hours on a sunny beach were divided into two groups: One sat under a beach umbrella with no other sun protection; the other applied SPF 100+ sunscreen, without any umbrella coverage.

Afterwards, 78% of people in the umbrella group showed signs of sunburn versus just 25% in the sunscreen group, suggesting that the sunscreen offered significantly better protection.

“Umbrella shade alone may not provide sufficient protection for extended sun exposure,” says the study’s lead author Hao Ou-Yang, Ph.D., Manager, Medical Research, R&D Fellow, Johnson & Johnson. “Although using SPF 100 was better than simply sitting in the shade, neither prevents sunburn completely. That’s why it’s essential to use a combination of sun protection methods.”

So when you get to the beach (or sit outside anywhere on a bright day), opt for multiple forms of protection—such as sunscreen, shade and hats—and then crack open a novel and order that fruity drink.

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.